The integration of AI into the health care industry could produce remarkable savings for the United States, projected at 360 billion US dollars. This idea appeared in a report by researchers from McKinsey and Harvard. Artificial intelligence (AI) and automatic learning (ML) revolutionize medical devices, drug development, diagnosis and treatment. By automating tasks, they complete the work of health care practitioners, promising to advance decision -making, reduce costs and improve patient experience.
Related:: AI opens the way to advance the detection of early diseases
Medical devices fed by AI
In 2022, the United States Food and Drug Administration (FDA) authorized 91 medical devices equipped with AI or ML capabilities. This category covers important algorithms and sophisticated automatic learning tools. Such an example is an atrial fibrillation history incorporated in the Apple Watch. Another tool designed by AIDOC, an IA company in radiology, has received the release of the FDA for its functionality fueled by AI, designed to detect the collapsed lungs on X -ray images. This rationalizes the diagnostic process and allows doctors to prioritize critical images.
Digital biomarkers generated by AI
The fusion of physiological data with lifestyle and environmental factors opens the way to deep phenotyping. Coupled with genomics, this should bring health care to new heights. Bloodomer Tech combines advanced fabric technology with ML to transform clothing, for example, women’s bras, portable medical devices. The role of AI in the generation of digital biomarkers promises transformative impacts, in particular for diseases that affect women disproportionately. Bloomer Tech’s goal lies in the cardiovascular system in women, given the challenges of diagnostics and treatment. The company aims to pass limited biomarkers analyzed in laboratories to ideas focused on AI from clothing. This change could revolutionize health care by allowing proactive and preventive care.
Ia in clinical decision support
The AI AI -based clinical decision support software is another innovation likely to transform patient care by analyzing the historic, current and incoming patients of patients. The software can identify security problems, errors and collection possibilities to improve care routes. The CDSS CDSS could improve the diagnosis, treatment and prognosis of specific medical conditions. The FDA has published new guidelines that certain AI tools should be regulated as medical devices, in particular those predicting sepsis, patient deterioration and heart failure. This change reflects the growing use of AI and ML, which can improve performance by learning from experience.
The development of drugs has revolutionized by AI
AI can accelerate the development of new drugs and technology reshapes the process, which stimulates significant improvements. The development of drugs takes 12 to 18 years, which costs $ 2 billion US dollars, with only 10% approval. The AI can speed up R&D, reduce costs and increase the chances of drug approval. COVID-19 accelerated the adoption of AI in the discovery of drugs, a turning point for the pharmaceutical industry. In February 2020, Eli Lilly’s Olumant was identified by the UK-based start-up Benevolentai as a COVVI-19 potential treatment, receiving an Emergency Authorization from the FDA in just three days.
The impact of AI on value -based care
Another revolutionary innovation. AI has enormous potential for improving operational efficiency and results for patients, creating shared savings opportunities. The health care sector achieves the advantages of using AI to analyze health trends and provides higher -based care. David Friede, vice-president of strategic partnerships for the Drowl application, highlights an example where AI creates a digital twin of a patient, allowing the exploration of treatments and results. This approach improves patients’ journey and overall health care experience.
In relation: The current status and the future potential of AI in medical imaging
As this progress fueled by AI takes place, the influence of AI in health care is simply revolutionary. Progress promises to reshape health care, allowing a future where innovation, precision and patient care is essential. The AI should strengthen, and not replace a human judgment leading to faster and more enlightened decisions, to lower costs and, ultimately, to care for improved patients.
This article appears in the latest issue of Omnia Health magazine, read more here